Singapore, April 9 -- UK-based Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, has announced a significant expansion of its Asia Pacific (APAC) distributor network. This development marks a key milestone in the company's global commercial strategy to meet growing demand for its next-generation single-cell analysis platforms.

The expansion enhances Sphere Bio's footprint across key Asian and Pacific markets, improving regional access to its innovative technologies, local support, and technical expertise.

The company has formed partnerships with five new distributors:1st PhileKorea(South Korea),AS ONE Corporation(Japan),Decode Science(Australia and New Zealand),Everlife ...